Three-Drug Diabetes Pill Shows Superior Glycemic Control Over Dual Therapy

Clinical trial results indicate that a fixed-dose combination pill containing dapagliflozin, glimepiride, and metformin provides better glycemic control compared to dual therapy in diabetes treatment. This finding suggests potential improvements in managing blood sugar levels for diabetic patients.

Originally published by gnews